Concord Biotech Share Price
1419.30-28.40 (-1.96%)
-16.46% past 1 Year
News
Concord Biotech Q1 EBITDA rises sharply with improved margin performance
Equity
CONCORDBIO
Concord Biotech posts strong Q1 revenue growth on robust year-on-year performance
Equity
CONCORDBIO
Concord Biotech reports higher Q1 net profit on steady quarterly earnings
Equity
CONCORDBIO
Concord Biotech schedules Q1 FY2026 earnings conference call for investors
Equity
CONCORDBIO
Concord Biotech clears Kenya, Uganda inspections at Unit-II formulation plant
Equity
CONCORDBIO
Brazilian Health Regulatory Agency completes inspection at Concord Biotech’s API manufacturing facility in Limbasi
Equity
CONCORDBIO
Concord Biotech completes Anvisa inspection at Limbasi API site
Equity
CONCORDBIO
Concord Biotech zooms after getting USFDA’s nod for Tofacitinib Tablets
Equity
CONCORDBIO
Concord Biotech gets USFDA’s nod for Tofacitinib Tablets
Equity
CONCORDBIO
Concord Biotech gains USFDA nod for Tofacitinib tablets with US sales potential
Equity
CONCORDBIO
Concord Biotech soars on getting USFDA nod for Mycophenolate Mofetil for Oral Suspension
Equity
CONCORDBIO
Concord Biotech gets USFDA nod for Mycophenolate Mofetil oral suspension
Equity
CONCORDBIO
Kotak maintains Add rating on Concord Biotech with strong FY27–29 growth view
Equity
CONCORDBIO
Jefferies keeps Hold rating on Concord Biotech after weak Q4 print
Equity
CONCORDBIO
Concord Biotech informs about press release
Equity
CONCORDBIO
Concord Biotech upbeat on FY27 growth outlook from products, customers mix shift
Equity
CONCORDBIO
Concord Biotech - Quaterly Results
Equity
CONCORDBIO
Concord Biotech Q4 EBITDA declines sharply with margin compression YoY
Equity
CONCORDBIO
Concord Biotech reports lower Q4 profit and revenue year on year
Equity
CONCORDBIO
Concord Biotech reports Profit after tax of 90.02 Crores, in the March 2026 quarter
Equity
CONCORDBIO